Indonesia vs Liberia: Treatment success rate for patients treated for MDR-TB
Indonesia
59.0%
in 2022
Liberia
59.0%
in 2022
Indonesia rank
125th
Liberia rank
125th
Treatment success rate for patients treated for MDR-TB over time
- Indonesia
- Liberia
How they compare
Indonesia currently reports 59.0% against 59.0% in Liberia, a difference of 0.0%.
The two have swapped places 1 time across 8 shared years of data; in 2009 it was Indonesia ahead.
Indonesia ranks 125th and Liberia ranks 125th of 163 countries.
Across the 3 decades both report, Indonesia averaged higher in 1 and Liberia in 2.
Head to head by decade
| Decade | Indonesia | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.0% | 20.0% | 54.0% | Indonesia |
| 2010s | 46.8% | 74.8% | 28.0% | Liberia |
| 2020s | 56.0% | 76.0% | 20.0% | Liberia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Indonesia or Liberia?
- Indonesia, at 59.0% against 59.0% in Liberia as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Indonesia and Liberia?
- 0.0%, with Indonesia ahead.
- How many years of comparable data are there for Indonesia and Liberia?
- 8 years are reported by both, from 2009 to 2022.
- How do Indonesia and Liberia rank globally for treatment success rate for patients treated for mdr-tb?
- Indonesia ranks 125th and Liberia ranks 125th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.